pd 117302 has been researched along with dihydropyridines in 1 studies
Studies (pd 117302) | Trials (pd 117302) | Recent Studies (post-2010) (pd 117302) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
---|---|---|---|---|---|
48 | 0 | 2 | 5,022 | 529 | 969 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gullapalli, S; Ramarao, P | 1 |
1 other study(ies) available for pd 117302 and dihydropyridines
Article | Year |
---|---|
L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Benzeneacetamides; Calcium Channels, L-Type; Cannabinoids; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Male; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Thiophenes | 2002 |